Credential Qtrade Securities Inc. Ab Cellera Biologics Inc. Transaction History

Credential Qtrade Securities Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jul 21, 2025	SELL	$9.48 - $14.52 $1,033 - $1,582	-109 Closed	0 $0
Q3 2021 Jul 21, 2025	SELL	$14.85 - $21.34 $392,782 - $564,443	-26,450 Reduced 99.59%	109 $2.18 Million
Q2 2021 Jul 21, 2025	BUY	$20.19 - $34.17 $534,025 - $903,796	26,450 Added 24266.06%	26,559 $584 Million
Q1 2021 Jul 21, 2025	BUY	$23.29 - $53.2 $2,538 - $5,798	109 New	109 $3.7 Million

153

132M

156K

346K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.46B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.